Orange Book product
NAROPIN 50MG/10ML (5MG/ML) **Federal Register determination that…
Orange Book NDA 020533 · FRESENIUS KABI USA LLC · Discontinued
Key facts
| Proprietary name | NAROPIN |
|---|---|
| Active ingredients | ROPIVACAINE HYDROCHLORIDE |
| Strength | 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | SOLUTION |
| Route | INJECTION |
| Application | NDA020533 |
| Applicant holder | FRESENIUS KABI USA LLC |
| Marketing status | Discontinued |
| Reference listed drug (RLD) | Yes |
| Reference standard (RS) | No |
| Approval date | May 1, 1998 |
At a glance
- None Marketed products with the same ingredient, strength and form
- 10–99 Products in this application
- Yes Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.